Skip to main content

Advertisement

Log in

Epidemiology of esophageal cancer: update in global trends, etiology and risk factors

  • Clinical Review
  • Published:
Clinical Journal of Gastroenterology Aims and scope Submit manuscript

Abstract

Esophageal cancer is the eighth most common type of cancer worldwide and constitutes the sixth leading cause of cancer deaths. It is characterized by its high mortality rate, poor prognosis at time of diagnosis and variability based on geographic location. Present day, the prevalence of esophageal cancer is in transition. Although esophageal squamous cell carcinoma continues to be the most prevalent type worldwide, esophageal adenocarcinoma is quickly becoming the most prevalent type in developed countries. Risk factors for the development of esophageal squamous cell carcinoma include low socioeconomic status, consumption of tobacco, alcohol, hot beverages, and nitrosamines. Additionally, micronutrient deficiencies have also been linked to the development of esophageal squamous cell cancer. These include vitamin C, vitamin E, and folate. With respect to esophageal adenocarcinoma, risk factors include Barrett's esophagus, gastroesophageal reflux disease, obesity, and tobacco consumption. Screening for esophageal cancer will likely play an essential role in prevention, and consequently, mortality in the future. Present day, there are no established guidelines for esophageal squamous cell cancer screening. Guidelines for esophageal adenocarcinoma are more well established but lack concrete evidence in the form of randomized controlled trials. This review will discuss the epidemiology, risk factors, and current prevention strategies for esophageal cancer in depth. It is our aim to raise awareness on the aforementioned topics to increase public health efforts in eradicating this disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

reproduced from https://globocan.iarc.fr/ [13])

Fig. 3
Fig. 4
Fig. 5
Fig. 6

reproduced from https://globocan.iarc.fr/ [13])

Similar content being viewed by others

References

  1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424.

    PubMed  Google Scholar 

  2. Umar S, Fleischer D. Esophageal cancer: epidemiology, pathogenesis and prevention. Nat Rev GastroenterolHepatol. 2008;5:517–26.

    Article  Google Scholar 

  3. Ilson DH, van Hillegersberg R. Management of patients with adenocarcinoma or squamous cancer of the esophagus. Gastroenterology. 2018;154:437–51.

    Article  PubMed  Google Scholar 

  4. Howlader N, Noone AM, Krapcho M, et al. SEER Cancer Statistics Review, 1975–2016, National Cancer Institute. Bethesda, MD, https://seer.cancer.gov/csr/1975_2016/, based on November 2018 SEER data submission, posted to the SEER web site, April 2019. Accessed 23 February 2020.

  5. Njei B, McCarty TR, Birk JW. Trends in esophageal cancer survival in United States adults from 1973 to 2009: a SEER database analysis. J GastroenterolHepatol. 2016;31:1141–6.

    Google Scholar 

  6. Pickens A, Orringer MB. Geographical distribution and racial disparity in esophageal cancer. Ann ThoracSurg. 2003;76:S1367–S13691369.

    Article  Google Scholar 

  7. Arnold M, Soerjomataram I, Ferlay J, Forman D. Global incidence of oesophageal cancer by histological subtype in 2012. Gut. 2015;64:381–7.

    Article  PubMed  Google Scholar 

  8. Ferlay J, Ervik M, Lam F, et al. Global cancer observatory: cancer today. International Agency for Research on Cancer, Lyon, France. Available from: https://gco.iarc.fr/today. Accessed 05 March 2020.

  9. Global Burden of Disease Cancer Collaboration. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study. JAMA Oncol. 2017;3:524–48.

    Article  PubMed Central  Google Scholar 

  10. Montgomery EA (2014) Oesophageal Cancer. In: Stewart BW, Wild CP (Eds) World Cancer Report 2014. World Health Organization. p 374–82.

  11. Chen W, Zheng R, Zeng H, et al. Annual report on status of cancer in China, 2011. Chin J Cancer Res. 2015;27:2–12.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  12. Arnold M, Laversanne M, Brown LM, et al. Predicting the future burden of esophageal cancer by histological subtype: international trends in incidence up to 2030. Am J Gastroenterol. 2017;112:1247–55.

    Article  PubMed  Google Scholar 

  13. Ferlay J, Ervik M, Lam F, et al. Global Cancer Observatory: Cancer Tomorrow. Lyon, France: International Agency for Research on Cancer. 2018. Available from: https://gco.iarc.fr/tomorrow, accessed 15 March 2020.

  14. Gavin AT, Francisci S, Foschi R, et al. EUROCARE-4 Working Group. Oesophageal cancer survival in Europe: a EUROCARE-4 study. Cancer Epidemiol. 2012;36:505–12.

    Article  CAS  PubMed  Google Scholar 

  15. Huang FL, Yu SJ. Esophageal cancer: Risk factors, genetic association, and treatment. Asian J Surg. 2018;41:210–5.

    Article  PubMed  Google Scholar 

  16. Hoyo C, Cook MB, Kamangar F, et al. Body mass index in relation to oesophageal and oesophagogastric junction adenocarcinomas: a pooled analysis from the International BEACON Consortium. Int J Epidemiol. 2012;41:1706–18.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Corley DA, Kubo A, Zhao W. Abdominal obesity and the risk of esophageal and gastric cardia carcinomas. Cancer Epidemiol Biomarkers Prev. 2008;17:352–8.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Lindkvist B, Johansen D, Stocks T, et al. Metabolic risk factors for esophageal squamous cell carcinoma and adenocarcinoma: a prospective study of 580,000 subjects within the Me-Can project. BMC Cancer. 2014;14:103.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  19. Steffen A, Schulze MB, Pischon T, et al. Anthropometry and esophageal cancer risk in the European prospective investigation into cancer and nutrition. Cancer Epidemiol Biomarkers Prev. 2009;18:2079–89.

    Article  PubMed  Google Scholar 

  20. Siewert JR, Ott K. Are squamous and adenocarcinomas of the esophagus the same disease? SeminRadiat Oncol. 2007;17:38–44.

    Google Scholar 

  21. Arnold M, Colquhoun A, Cook MB, et al. Obesity and the incidence of upper gastrointestinal cancers: an ecological approach to examine differences across age and sex. Cancer Epidemiol Biomarkers Prev. 2016;25:90–7.

    Article  PubMed  Google Scholar 

  22. Cronin-Fenton DP, Murray LJ, Whiteman DC, et al. Reproductive and sex hormonal factors and oesophageal and gastric junction adenocarcinoma: a pooled analysis. Eur J Cancer. 2010;46:2067–76.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Dhillon PK, Farrow DC, Vaughan TL, et al. Family history of cancer and risk of esophageal and gastric cancers in the United States. Int J Cancer. 2001;93:148–52.

    Article  CAS  PubMed  Google Scholar 

  24. Turati F, Edefonti V, Bosetti C, et al. Family history of cancer and the risk of cancer: a network of case-control studies. Ann Oncol. 2013;24:2651–6.

    Article  CAS  PubMed  Google Scholar 

  25. Chen T, Cheng H, Chen X, et al. Family history of esophageal cancer increases the risk of esophageal squamous cell carcinoma. Sci Rep. 2015;5:16038.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Su Z, Zou GR, Mao YP, et al. Prognostic impact of family history of cancer in Southern Chinese patients with esophageal squamous cell cancer. J Cancer. 2019;10:1349–57.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Jia N, Wen X, Zhang N, et al. Younger age of onset and multiple primary lesions associated with esophageal squamous cell carcinoma cases with a positive family history of the cancer suggests genetic predisposition. Chin Med J (Engl). 2014;127:2779–833.

    Google Scholar 

  28. Jiang X, Tseng CC, Bernstein L, et al. Family history of cancer and gastroesophageal disorders and risk of esophageal and gastric adenocarcinomas: a case-control study. BMC Cancer. 2014;14:60.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Turati F, Negri E, La Vecchia C. Family history and the risk of cancer: genetic factors influencing multiple cancer sites. Expert Rev Anticancer Ther. 2014;14:1–4.

    Article  CAS  PubMed  Google Scholar 

  30. Rosenberg PS, Greene MH, Alter BP. Cancer incidence in persons with Fanconi anemia. Blood. 2003;101:822–6.

    Article  CAS  PubMed  Google Scholar 

  31. Buas MF, He Q, Johnson LG, et al. Germline variation in inflammation-related pathways and risk of Barrett's oesophagus and oesophageal adenocarcinoma. Gut. 2017;66:1739–47.

    Article  CAS  PubMed  Google Scholar 

  32. Lewis SJ, Smith GD. Alcohol, ALDH2, and esophageal cancer: a meta-analysis which illustrates the potentials and limitations of a Mendelian randomization approach. Cancer Epidemiol Biomarkers Prev. 2005;14:1967–71.

    Article  CAS  PubMed  Google Scholar 

  33. Blot WJ, Tarone RE. Esophageal cancer. In: Thun MJ, Linet MS, Cerhan JR, Haiman CA, Schottenfeld D, editors. Cancer epidemiology and prevention. 4th ed. New York: Oxford University Press; 2018. p. 579–592.

    Google Scholar 

  34. Renehan AG, Tyson M, Egger M, et al. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet. 2008;371:569–78.

    Article  PubMed  Google Scholar 

  35. Holmes RS, Vaughan TL. Epidemiology and pathogenesis of esophageal cancer. SeminRadiat Oncol. 2007;17:2–9.

    Google Scholar 

  36. Choi YJ, Lee DH, Han K-D, et al. The relationship between drinking alcohol and esophageal, gastric or colorectal cancer: a nationwide population-based cohort study of South Korea. PLoS ONE. 2017;12:e0185778.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  37. Pandeya N, Williams G, Green AC, et al. Alcohol consumption and the risks of adenocarcinoma and squamous cell carcinoma of the esophagus. Gastroenterology. 2009;136:1215–24.

    Article  CAS  PubMed  Google Scholar 

  38. Toh Y, Oki E, Ohgaki K, et al. Alcohol drinking, cigarette smoking, and the development of squamous cell carcinoma of the esophagus: molecular mechanisms of carcinogenesis. Int J Clin Oncol. 2010;15:135–44.

    Article  CAS  PubMed  Google Scholar 

  39. DomperArnal MJ, Arenas F, Arbeloa L. Esophageal cancer: Risk factors, screening and endoscopic treatment in Western and Eastern countries. World J Gastroenterol. 2015;21:7933–43.

    Article  Google Scholar 

  40. Anderson LA, Cantwell MM, Watson RG, et al. The association between alcohol and reflux esophagitis, Barrett's esophagus, and esophageal adenocarcinoma. Gastroenterology. 2009;136:799–805.

    Article  CAS  PubMed  Google Scholar 

  41. Pandeya N, Olsen CM, Whiteman DC. Sex differences in the proportion of esophageal squamous cell carcinoma cases attributable to tobacco smoking and alcohol consumption. Cancer Epidemiol. 2013;37:579–84.

    Article  CAS  PubMed  Google Scholar 

  42. Dong J, Thrift AP. Alcohol, smoking and risk of oesophago-gastric cancer. Best Pract Res ClinGastroenterol. 2017;31:509–17.

    Article  Google Scholar 

  43. Bosetti C, Gallus S, Garavello W, et al. Smoking cessation and the risk of oesophageal cancer: an overview of published studies. Oral Oncol. 2006;42:957–64.

    Article  PubMed  Google Scholar 

  44. Hardikar S, Onstad L, Blount PL, et al (2013) The role of tobacco, alcohol, and obesity in neoplastic progression to esophageal adenocarcinoma: a prospective study of Barrett's esophagus. PloS one. 8.

  45. Cook MB, Kamangar F, Whiteman DC, Freedman ND, Gammon MD, Bernstein L, Brown LM, Risch HA, Ye W, Sharp L, Pandeya N, Webb PM, Wu AH, et al. Cigarette smoking and adenocarcinomas of the esophagus and esophagogastric junction: a pooled analysis from the international BEACON consortium. JNCI J Natl Cancer Inst. 2010;102:1344–53. https://doi.org/10.1093/jnci/djq289.

    Article  CAS  PubMed  Google Scholar 

  46. Liu J, Wang J, Leng Y, et al. Intake of fruit and vegetables and risk of esophageal squamous cell carcinoma: a meta-analysis of observational studies. Int J Cancer. 2013;133:473–85.

    Article  CAS  PubMed  Google Scholar 

  47. World Cancer Research Fund/American Institute for Cancer Research. Diet, Nutrition, Physical Activity and Cancer: a Global Perspective. Continuous Update Project Expert Report 2018. Available at https://dietandcancerreport.org. Accessed 24 Aug 2020.

  48. Zhao Y, Guo C, Hu H, et al. Folate intake, serum folate levels and esophageal cancer risk: an overall and dose-response meta-analysis. Oncotarget. 2017;8:10458–69.

    Article  PubMed  PubMed Central  Google Scholar 

  49. Zgaga L, O'Sullivan F, Cantwell MM, et al. Markers of Vitamin D exposure and esophageal cancer risk: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev. 2016;25:877–86.

    Article  CAS  PubMed  Google Scholar 

  50. Chen Y, Tong Y, Yang C, et al. Consumption of hot beverages and foods and the risk of esophageal cancer: a meta-analysis of observational studies. BMC cancer. 2015;15:449.

    Article  PubMed  PubMed Central  Google Scholar 

  51. Zhang J, Zhou B, Hao C. Coffee consumption and risk of esophageal cancer incidence: a meta-analysis of epidemiologic studies. Medicine (Baltimore). 2018;97:e0514.

    Article  Google Scholar 

  52. Qu X, Ben Q, Jiang Y. Consumption of red and processed meat and risk for esophageal squamous cell carcinoma based on a meta-analysis. Ann Epidemiol. 2013;23:762–70.

    Article  PubMed  Google Scholar 

  53. Kubo A, Levin TR, Block G, et al. Dietary patterns and the risk of Barrett's esophagus. Am J Epidemiol. 2008;167:839–46.

    Article  PubMed  Google Scholar 

  54. Pan D, Su M, Zhang T, et al. A distinct epidemiologic pattern of precancerous lesions of esophageal squamous cell carcinoma in a high-risk area of Huai'an, Jiangsu Province, China. Cancer Prev Res (Phila). 2019;12:449–62.

    Article  Google Scholar 

  55. Marshall B, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet. 1984;323(8390):1311–5.

    Article  Google Scholar 

  56. Ahn HJ, Lee DS. Helicobacter pylori in gastric carcinogenesis. World J Gastrointest Oncol. 2015;7:455–65.

    Article  PubMed  PubMed Central  Google Scholar 

  57. Hooi JKY, Lai WY, Ng WK, et al. Global prevalence of helicobacter pylori infection: systematic review and meta-analysis. Gastroenterology. 2017;153:420–9.

    Article  PubMed  Google Scholar 

  58. Islami F, Kamangar F. Helicobacter pylori and esophageal cancer risk: a meta-analysis. Cancer Prev Res (Phila). 2008;1:329–38.

    Article  CAS  Google Scholar 

  59. Nie S, Chen T, Yang X, et al. Association of helicobacter pylori infection with esophageal adenocarcinoma and squamous cell carcinoma: a meta-analysis. Dis Esophagus. 2014;27:645–53.

    Article  CAS  PubMed  Google Scholar 

  60. Anderson LA, Johnston BT, Watson RG, et al. Nonsteroidal anti-inflammatory drugs and the esophageal inflammation-metaplasia-adenocarcinoma sequence. Cancer Res. 2006;66:4975–82.

    Article  CAS  PubMed  Google Scholar 

  61. Kastelein F, Spaander MC, Biermann K, et al. Probar-study Group. Nonsteroidal anti-inflammatory drugs and statins have chemopreventative effects in patients with Barrett's esophagus. Gastroenterology. 2011;141:2000–8.

    Article  CAS  PubMed  Google Scholar 

  62. Nguyen DM, Richardson P, El-Serag HB. Medications (NSAIDs, statins, proton pump inhibitors) and the risk of esophageal adenocarcinoma in patients with Barrett's esophagus. Gastroenterology. 2010;138:2260–6.

    Article  PubMed  Google Scholar 

  63. Singh S, Garg SK, Singh PP, et al. Acid-suppressive medications and risk of oesophageal adenocarcinoma in patients with Barrett's oesophagus: a systematic review and meta-analysis. Gut. 2014;63:1229–377.

    Article  PubMed  Google Scholar 

  64. Lacroix O, Couttenier A, Vaes E, et al. Statin use after diagnosis is associated with an increased survival in esophageal cancer patients: a Belgian population-based study. Cancer Causes Control. 2019;30:385–93.

    Article  PubMed  Google Scholar 

  65. Wheeler JB, Reed CE. Epidemiology of esophageal cancer. SurgClin North Am. 2012;92:1077–87.

    Article  Google Scholar 

  66. Lee CH, Lee JM, Wu DC, et al. Independent and combined effects of alcohol intake, tobacco smoking and betel quid chewing on the risk of esophageal cancer in Taiwan. Int J Cancer. 2005;113:475–82.

    Article  CAS  PubMed  Google Scholar 

  67. Offermans NS, Vermeulen R, Burdorf A, et al. Occupational asbestos exposure and risk of esophageal, gastric and colorectal cancer in the prospective Netherlands Cohort Study. Int J Cancer. 2014;135:1970–7.

    Article  CAS  PubMed  Google Scholar 

  68. Roshandel G, Semnani S, Malekzadeh R, et al. Polycyclic aromatic hydrocarbons and esophageal squamous cell carcinoma. Arch Iran Med. 2012;15:713–22.

    CAS  PubMed  PubMed Central  Google Scholar 

  69. Jansson C, Plato N, Johansson AL, et al. Airborne occupational exposures and risk of oesophageal and cardia adenocarcinoma. Occup Environ Med. 2006;63:107–12.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  70. Lopes AB, Fagundes RB. Esophageal squamous cell carcinoma—precursor lesions and early diagnosis. World J GastrointestEndosc. 2012;4:9–16.

    Article  Google Scholar 

  71. Hamel C, Ahmadzai N, Beck A, et al. (2020) Screening for esophageal adenocarcinoma and precancerous conditions (dysplasia and Barrett’s esophagus) in patients with chronic gastroesophageal reflux disease with or without other risk factors: two systematic reviews and one overview of reviews to inform a guideline of the Canadian Task Force on Preventive Health Care (CTFPHC). Syst Rev. 9.

  72. Yokoyama T, Yokoyama A, Kumagai Y, et al. Health risk appraisal models for mass screening of esophageal cancer in Japanese men. Cancer Epidemiol Biomarkers Prev. 2008;17(10):2846–54. https://doi.org/10.1158/1055-9965.EPI-08-0397.

    Article  CAS  PubMed  Google Scholar 

  73. Gavin AT, Francisci S, Foschi R, et al. Oesophageal cancer survival in Europe: a EUROCARE-4 study. Cancer Epidemiol. 2012;36:505–12.

    Article  CAS  PubMed  Google Scholar 

  74. Hou H, Meng Z, Zhao X, et al. Survival of esophageal cancer in China: a pooled analysis on hospital-based studies From 2000 to 2018. Front Oncol. 2019;9:548.

    Article  PubMed  PubMed Central  Google Scholar 

  75. Qin J, Zhu HD, Guo JH, et al. Factors associated with overall survival and relief of dysphagia in advanced esophageal cancer patients after 125I seed-loaded stent placement: a multicenter retrospective analysis. Dis Esophagus. 2019;32:doz012.

    PubMed  Google Scholar 

  76. Smyth EC, Lagergren J, Fitzgerald RC, et al. Oesophageal cancer. Nat Rev Dis Primers. 2017;3:17048.

    Article  PubMed  PubMed Central  Google Scholar 

  77. Asombang AW, Chishinga N, Nkhoma A, et al. Systematic review and meta-analysis of esophageal cancer in Africa: epidemiology, risk factors, management and outcomes. World J Gastroenterol. 2019;25:4512–33.

    Article  PubMed  PubMed Central  Google Scholar 

  78. Coleman HG, Xie SH, Lagergren J. The epidemiology of esophageal adenocarcinoma. Gastroenterology. 2018;154:390–405.

    Article  PubMed  Google Scholar 

  79. Zeng H, Zheng R, Guo Y, et al. Cancer survival in China, 2003–2005: a population-based study. Int J Cancer. 2015;136:1921–30.

    Article  CAS  PubMed  Google Scholar 

  80. Van Loon K, Mwachiro MM, Abnet CC, et al. The African esophageal cancer consortium: a call to action. J Glob Oncol. 2018;4:1–9.

    PubMed  Google Scholar 

  81. Chung CS, Lee YC, Wu MS. Prevention strategies for esophageal cancer: perspectives of the East vs West. Best Pract Res ClinGastroenterol. 2015;29:869–83.

    Article  Google Scholar 

  82. Siti-Azrin AH, Wan-Nor-Asyikeen WA, Norsa'adah B. Review of the burden of esophageal cancer in Malaysia. Asian Pac J Cancer Prev. 2016;17:3705–9.

    PubMed  Google Scholar 

  83. Guo LW, Huang HY, Shi JF, et al. Medical expenditure for esophageal cancer in China: a 10-year multicenter retrospective survey (2002–2011). Chin J Cancer. 2017;36:73.

    Article  PubMed  PubMed Central  Google Scholar 

  84. Abnet CC, Arnold M, Wei WQ. Epidemiology of esophageal squamous cell carcinoma. Gastroenterology. 2018;154:360–73.

    Article  PubMed  Google Scholar 

  85. Lin Y, Totsuka Y, Shan B, et al. Esophageal cancer in high-risk areas of China: research progress and challenges. Ann Epidemiol. 2017;27:215–21.

    Article  PubMed  Google Scholar 

  86. Kitagawa Y, Uno T, Oyama T, et al. Esophageal cancer practice guidelines 2017 edited by the Japan Esophageal Society: part 1. Esophagus. 2019;16:1–24.

    Article  PubMed  Google Scholar 

  87. Bo Y, Lu Y, Zhao Y, et al. Association between dietary vitamin C intake and risk of esophageal cancer: a dose-response meta-analysis. Int J Cancer. 2016;138:1843–50.

    Article  CAS  PubMed  Google Scholar 

  88. Deng HY, Lan X, Zheng X, et al. The association between statin use and survival of esophageal cancer patients: a systematic review and meta-analysis. Medicine (Baltimore). 2019;98:e16480.

    Article  CAS  Google Scholar 

  89. Yang W, Han Y, Zhao X, et al. Advances in prognostic biomarkers for esophageal cancer. Expert Rev MolDiagn. 2019;19:109–19.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The authors would like to recognize the contribution of cancer registry staff who collected the data used in this review.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Dustin J. Uhlenhopp.

Ethics declarations

Conflict of interest

The authors declare that there is no conflict of interest regarding the publication of this paper.

Human and animal rights

This article does not contain any studies directly involving human participants, as it is a review of data already collected in multiple cancer databases.

Informed consent

For this type of study/review, formal consent is not required.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Uhlenhopp, D.J., Then, E.O., Sunkara, T. et al. Epidemiology of esophageal cancer: update in global trends, etiology and risk factors. Clin J Gastroenterol 13, 1010–1021 (2020). https://doi.org/10.1007/s12328-020-01237-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12328-020-01237-x

Keywords

Navigation